VolitionRx Limited (VNRX)

VolitionRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	1.12	3.26	20.73
Cash & Short-Term Investments	1.12	3.26	20.73
Cash Growth	-65.78%	-84.25%	-
Accounts Receivable	0.32	0.11	0.24
Other Current Assets	0.63	0.68	0.88
Total Current Assets	2.06	4.06	21.85
Net Property, Plant & Equipment	4.52	5.03	6.07
Other Intangible Assets	0.32	0.31	0.02
Total Assets	6.9	9.4	27.95
Accounts Payable	2.92	2.77	3.21
Accrued Expenses	4.29	3.51	3.99
Current Portion of Long-Term Debt	3.43	0.92	1.26
Current Portion of Leases	0.3	0.27	0.25
Unearned Revenue	0.35	0.23	0.11
Other Current Liabilities	0.93	0.1	0.13
Total Current Liabilities	12.23	7.79	8.94
Long-Term Debt	7.73	4.31	4.05
Long-Term Leases	0.59	0.74	0.78
Other Long-Term Liabilities	21.94	22.66	22.89
Total Long-Term Liabilities	30.26	27.72	27.72
Total Liabilities	42.49	35.51	36.66
Common Stock	0.13	0.1	0.08
Additional Paid-in Capital	218.82	204.15	194.45
Accumulated Other Comprehensive Income	-0.3	0.39	0.24
Retained Earnings	-252.9	-229.54	-202.58
Total Common Shareholders' Equity	-34.25	-24.91	-7.8
Minority Interest	-1.35	-1.2	-0.91
Shareholders' Equity	-35.59	-26.11	-8.71
Total Liabilities & Equity	6.9	9.4	27.95
Total Debt	12.06	6.24	6.34
Net Cash (Debt)	-10.94	-2.98	14.39
Net Cash Per Share	-0.10	-0.03	0.20
Book Value	-34.25	-24.91	-7.8
Book Value Per Share	-0.32	-0.29	-0.11
Tangible Book Value	-34.56	-25.22	-7.83
Tangible Book Value Per Share	-0.32	-0.29	-0.11

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q